Abstract B72: Long-term survival and outcome update on patients (pts) with recurrent ovarian cancer who received Ipilimumab post GVAX vaccine von Matulonis, Ursula Anne, Hodi, Stephen, Dranoff, Glenn, Campos, Susana, Penson, Richard, Soiffer, Robert, Butler, Marcus

Volltext

Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer von Risch, Thomas, Fan, Jian-Bing, Holton, Kristina, Rubio, Renee, April, Craig, Wickham-Garcia, Eliza, Bentink, Stefan, Haibe-Kains, Benjamin, Hirsch, Michelle S, Chen, Jing, Liu, Joyce, Culhane, Aedin, Drapkin, Ronny I, Quackenbush, John, Matulonis, Ursula Anne

Volltext

Influence of Patients' Preferences and Treatment Site on Cancer Patients' End-of-Life Care von Wright, Alexi Anne, Mack, Jennifer Williams, Kritek, Patricia A, Balboni, Tracy, Massaro, Anthony Francis, Matulonis, Ursula Anne, Block, Susan Dale, Prigerson, Holly

Volltext

Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome von Wang, Z. C, Birkbak, N, Culhane, Aedin, Drapkin, R, Fatima, Aquila, Tian, R, Schwede, M, Alsop, K, Daniels, K. E, Piao, H, Liu, Joy, Etemadmoghadam, D, Miron, A, Salvesen, H. B, Mitchell, G, DeFazio, A, Quackenbush, John, Berkowitz, Ross Stuart, Iglehart, James Dirk, Bowtell, D. D. L, Matulonis, Ursula Anne

Volltext

CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations von Cramer, Daniel William, O'Rourke, D. J, Vitonis, A. F, Matulonis, Ursula Anne, DiJohnson, D. A, Sluss, Patrick M, Crum, Christopher Paul, Liu, B. C.- S

Volltext

Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1... von Howitt, Brooke Elizabeth, Shukla, Sachet, Sholl, Lynette Marie, Ritterhouse, Lauren Lee, Watkins, Jaclyn Christine, Rodig, Scott J, Stover, Elizabeth Harmon, Strickland, Kyle Craig, D'Andrea, Alan David, Wu, Catherine Ju-Ying, Matulonis, Ursula Anne, Konstantinopoulos, Panagiotis

Volltext

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial von Del Campo, Josep M, Matulonis, Ursula A, Malander, Susanne, Provencher, Diane, Mahner, Sven, Follana, Philippe, Waters, Justin, Berek, Jonathan S, Woie, Kathrine, Oza, Amit M, Canzler, Ulrich, Gil-Martin, Marta, Lesoin, Anne, Monk, Bradley J, Lund, Bente, Gilbert, Lucy, Wenham, Robert M, Benigno, Benedict, Arora, Sujata, Hazard, Sebastien J, Mirza, Mansoor R

Volltext

Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA... von Matulonis, Ursula A, Walder, Lydia, Nøttrup, Trine J, Bessette, Paul, Mahner, Sven, Gil-Martin, Marta, Kalbacher, Elsa, Ledermann, Jonathan A, Wenham, Robert M, Woie, Kathrine, Lau, Susie, Marmé, Frederik, Casado Herraez, Antonio, Hardy-Bessard, Anne-Claire, Banerjee, Susana, Lindahl, Gabriel, Benigno, Benedict, Buscema, Joseph, Travers, Karin, Guy, Holly, Mirza, Mansoor R

Volltext

Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial von Fabbro, Michel, Moore, Kathleen N., Dørum, Anne, Tinker, Anna V., Mahner, Sven, Bover, Isabel, Banerjee, Susana, Tognon, Germana, Goffin, Frederic, Shapira-Frommer, Ronnie, Wenham, Robert M., Hellman, Kristina, Provencher, Diane, Harter, Philipp, Vázquez, Isabel Palacio, Follana, Philippe, Pineda, Mario J., Mirza, Mansoor R., Hazard, Sebastien J., Matulonis, Ursula A.

Volltext

Comparison of the quality of life of early and advanced stage ovarian cancer survivors von Mirabeau-Beale, Kristina L, Kornblith, Alice B, Penson, Richard T, Lee, Hang, Goodman, Annekathryn, Campos, Susana M, Duska, Linda, Pereira, Lauren, Bryan, Jessica, Matulonis, Ursula A

Volltext

Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies von Sloane, David, MD, EdM, Govindarajulu, Usha, PhD, Harrow-Mortelliti, Jacob, BA, Barry, William, MD, PhD, Hsu, Florence Ida, MD, Hong, David, MD, Laidlaw, Tanya, MD, Palis, Ross, MD, Legere, Henry, MD, Bunyavanich, Supinda, MD, Breslow, Rebecca, MD, Wesemann, Duane, MD, PhD, Barrett, Nora, MD, Brennan, Patrick, MD, PhD, Chong, Hey Jin, MD, Liu, Anne, MD, Fernandez, James, MD, Fanning, Laura, MD, Kyin, Timothy, MD, Cahill, Katherine, MD, Bankova, Lora, MD, Lynch, Ashly, BA, Berlin, Suzanne, DO, Campos, Susana, MD, Fuchs, Charles, MD, MPH, Mayer, Robert, MD, Matulonis, Ursula, MD, Castells, Mariana, MD, PhD

Volltext

Acupuncture as Palliative Therapy for Physical Symptoms and Quality of Life for Advanced Cancer Patients von Dean-Clower, Elizabeth, Doherty-Gilman, Anne M., Keshaviah, Aparna, Baker, Frank, Kaw, Chiewkwei, Weidong Lu, Manola, Judith, Penson, Richard T., Matulonis, Ursula A., Rosenthal, David S.

Volltext

A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC) von Cadoo, Karen Anne, Meyers, Michael L., Burger, Robert Allen, Armstrong, Deborah Kay, Penson, Richard T., Gordon, Michael S., Fleming, Gini F., Moroney, John William, Hamilton, Erika Paige, Duska, Linda R., Wenham, Robert Michael, Sankoh, Serap, Brouwer, Susan, Ordentlich, Peter, Aghajanian, Carol, Matulonis, Ursula A.

Volltext

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer von Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Mądry, Radoslaw, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A

Volltext

Long-term benefit of niraparib treatment of recurrent ovarian cancer (OC) von Matulonis, Ursula A., Herrstedt, Jorn, Tinker, Anna, Marme, Frederik, Redondo, Andres, Kalbacher, Elsa, Ledermann, Jonathan A., Pikiel, Joanna, Christensen, Rene dePont, Berek, Jonathan S., Juhler-Nøttrup, Trine, Oza, Amit M., Meier, Werner, Gil-Martin, Marta, Hardy-Bessard, Anne-Claire, Monk, Bradley J., Rosenberg, Per, Wenham, Robert Michael, Hazard, Sebastien, Mirza, Mansoor Raza

Volltext

Efficacy of niraparib on progression-free survival (PFS) in patients (pts) with recurrent ovarian cancer (OC) with partial response (PR) to the last platinum-based chemotherapy von Mirza, Mansoor Raza, Monk, Bradley J., Gil-Martin, Marta, Gilbert, Lucy, Canzler, Ulrich, Follana, Philippe, Waters, Justin S., Kridelka, Frederic, Levy, Tally, Benigno, Benedict B., Woie, Kathrine, Provencher, Diane M., Lueck, Hans-Joachim, Casado Herraez, Antonio, Lesoin, Anne, Buscema, Joseph, Hellman, Kristina, Rimel, Bj, Hazard, Sebastien, Matulonis, Ursula A.

Volltext

The successful phase 3 niraparib ENGOT-OV16/NOVA trial included a substantial number of patients with platinum resistant ovarian cancer (OC) von Del Campo, Jose Maria, Mirza, Mansoor Raza, Berek, Jonathan S., Provencher, Diane M., Emons, Guenter, Fabbro, Michel, Lord, Rosemary, Colombo, Nicoletta, Petru, Edgar, Wenham, Robert Michael, Herrstedt, Jorn, Gilbert, Lucy, Heubner, Martin Leonhard, Gonzalez Martin, Antonio, Follana, Philippe, Benigno, Benedict B., Dørum, Anne, Rimel, Bj, Hazard, Sebastien, Matulonis, Ursula A.

Volltext

Transforming ovarian cancer care by targeting minimal residual disease von Jazaeri, Amir A, Grisham, Rachel, Knisely, Anne, Spranger, Stefani, Zamarin, Dmitriy, Hillman, R Tyler, Lawson, Barrett C, Burns, Kathleen H, Lee, Sanghoon, Westin, Shannon N, Moiso, Enrico, Williams, Marc J, Bardhan, Neelkanth M, Pisanic, Thomas, Matulonis, Ursula, Weigelt, Britta, Shih, IeMing, Konstantinopoulos, Panagiotis A, Gaillard, Stephanie, Wang, Linghua, Aghajanian, Carol, D'Andrea, Alan D, Hammond, Paula, Shah, Sohrab, Wucherpfennig, Kai W, Lu, Karen H

Volltext

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer von Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Mądry, Radosław, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A

Volltext

The Feasibility and Effects of Acupuncture on Quality of Life Scores During Chemotherapy in Ovarian Cancer: Results from a Pilot, Randomized Sham-Controlled Trial von Lu, Weidong, Matulonis, Ursula A, Dunn, Julie E, Lee, Hang, Doherty-Gilman, Anne, Dean-Clower, Elizabeth, Goodman, Annekathryn, Davis, Roger B, Buring, Julie, Wayne, Peter, Rosenthal, David S, Penson, Richard T

Volltext